Dubai: A Filipino-American scientist hopes to beat the coronavirus with a vaccine developed using baker’s yeast. By using bio-engineered yeast, the common single-celled fungal cells, Rev. Nicanor Austriaco hopes to transform COVID into a common cold. “The goal from this scrappy vaccine is not to prevent you from getting COVID. It’s actually to prevent you from getting severe COVID that will require hospitalisations,” the churchman-scientist told Gulf News.
Pre-clinical development
Rev. Austriaco, 52, earned his doctorate degree in yeast molecular biology from the Massachusetts Institute of Technology (MIT). His COVID-19 shot is currently in pre-clinical development in the US. A license to conduct clinical trials will be sought in the Philippines, the home of his ancestors, after the “mouse work” (test on animals), he added. He currently consults with the Manila government on the coronavirus pandemic response.
Recognizing the current global and national focus on the development and distribution of COVID-19 vaccines, the March 2021 installment of the President’s Speaker Series will present a moderated panel of leading medical, pharmaceutical, and biotechnology experts who will share their professional knowledge and experience with COVID-19 vaccines and examine what society might expect from vaccines in the future.
Stéphane Bancel, chief executive officer of Moderna, Stephen M. Hahn, former commissioner of food and drugs at the US Food and Drug Administration, and Jonathan B. Perlin, president of the Clinical Services Group and chief medical officer of HCA Healthcare, will present “Vaccines: Where Are We and Where Are We Going?” via Zoom on Monday, March 29, at 5 PM PDT. Dee Anna Smith (’86), CEO of Sarah Cannon, the Cancer Institute of HCA Healthcare, and chair of the Pepperdine Board of Regents, will moderate the discussion.
Rising gun sales could result in more deaths, injuries and suicides, health experts fear kold.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kold.com Daily Mail and Mail on Sunday newspapers.
E-Mail
SAN ANTONIO Surgically opening the windpipe, or trachea, within the first seven days of the start of mechanical ventilation decreases the time patients spend on ventilators, shortens their ICU stay and lowers their risk of ventilator-associated pneumonia, according to a systematic review published Thursday (March 11) in
JAMA Otolaryngology-Head & Neck Surgery. We analyzed the existing medical literature to unravel a question that is very pertinent to adult critical care, said senior author Alvaro Moreira, MD, MSc, of The University of Texas Health Science Center at San Antonio (UT Health San Antonio). At what point should surgeons open the trachea in critical care patients to most benefit them?
New report details how pandemic has impeded women s STEMM careers statnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from statnews.com Daily Mail and Mail on Sunday newspapers.